Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice

Abstract

BackgroundThe spread of drug-resistant bacterial pathogens poses a major threat to global health. It is widely recognised that the widespread use of antibiotics has generated selective pressures that have driven the emergence of resistant strains. Methicillin-resistant Staphylococcus aureus (MRSA) was first observed in 1960, less than one year after the introduction of this second generation beta-lactam antibiotic into clinical practice. Epidemiological evidence has always suggested that resistance arose around this period, when the mecA gene encoding methicillin resistance carried on an SCCmec element, was horizontally transferred to an intrinsically sensitive strain of S. aureus.ResultsWhole genome sequencing a collection of the first MRSA isolates allows us to reconstruct the evolutionary history of the archetypal MRSA. We apply Bayesian phylogenetic reconstruction to infer the time point at which this early MRSA lineage arose and when SCCmec was acquired. MRSA emerged in the mid-1940s, following the acquisition of an ancestral type I SCCmec element, some 14 years before the first therapeutic use of methicillin.ConclusionsMethicillin use was not the original driving factor in the evolution of MRSA as previously thought. Rather it was the widespread use of first generation beta-lactams such as penicillin in the years prior to the introduction of methicillin, which selected for S. aureus strains carrying the mecA determinant. Crucially this highlights how new drugs, introduced to circumvent known resistance mechanisms, can be rendered ineffective by unrecognised adaptations in the bacterial population due to the historic selective landscape created by the widespread use of other antibiotics.Electronic supplementary materialThe online version of this article (doi:10.1186/s13059-017-1252-9) contains supplementary material, which is available to authorized users.

Raising the stakes: Loss of efflux-pump regulation decreases meropenem susceptibility in Burkholderia pseudomallei

“…One example is in methicillin-resistant Staphylococcus aureus (MRSA), an important cause of community-and hospital-acquired infections worldwide (37). The first-documented MRSA clones are thought to have become resistant to methicillin approximately 14 years before the first use of this antibiotic in clinical practice, suggesting that resistance was not a consequence of methicillin-driven selection but rather first-generation p-lactam use (38). In this vein, it is noteworthy that Pre-DPMS 89 and P337 harbored strains with reduced meropenem sensitivity yet were never treated with this drug, although they were both given doxycycline and P337 was also administered TMP/SMX (Text S1).…”

Genomic Surveillance of Methicillin-ResistantStaphylococcus aureusin the Philippines from 2013-2014

“…20 Known AMR determinants and the Panton-Valentine leukocidin (PVL) lukF-PV and lukS-PV genes were identified from raw sequence reads using ARIBA 13 and a curated database of known resistance genes and mutations. 21 Genomic predictions of resistance were derived from the presence of known antimicrobial resistance genes and mutations identified in the genome sequences. The genomic predictions of AMR (test) were compared to the phenotypic results (reference) and the concordance between the two methods was computed for each of 8 antibiotics (928 total comparisons).…”

Antibiotic usage promotes the evolution of resistance against gepotidacin, a novel multi-targeting drug

“…However, we have demonstrated that two specific mutations in the genes encoding gepotidacin's targets can provide a very high level of resistance in multiple enterobacterial species 22 (see also Figure 2 According to what we term the "stepping-stone" hypothesis, prolonged clinical deployment of certain antibiotics may select for variants with an elevated potential to evolve resistance to new antimicrobial agents. For example, in Staphylococcus aureus the genetic alteration responsible for methicillin-resistance had emerged due to the selective pressure of first-generation beta-lactams, such as penicillin, years before methicillin was first applied in clinical practice 62 . Furthermore, the byproducts of drug degradation were also shown to promote resistance development against clinically applied antibacterials 63 .…”